US BioTec Inc
OTC:USBC
Cash Flow Statement
Cash Flow Statement
US BioTec Inc
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(15)
|
(15)
|
(15)
|
(16)
|
(17)
|
(18)
|
(16)
|
(13)
|
(22)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Stock-Based Compensation |
3
|
3
|
2
|
3
|
3
|
3
|
3
|
2
|
7
|
|
| Other Non-Cash Items |
4
|
4
|
5
|
5
|
5
|
7
|
7
|
6
|
13
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
(0)
|
2
|
|
| Cash from Operating Activities |
(10)
N/A
|
(11)
-5%
|
(11)
-2%
|
(11)
+1%
|
(13)
-17%
|
(11)
+12%
|
(9)
+21%
|
(8)
+14%
|
(8)
+2%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-2%
|
(0)
+38%
|
(0)
-29%
|
(0)
N/A
|
(0)
+19%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
6
|
6
|
6
|
6
|
5
|
5
|
6
|
7
|
16
|
|
| Net Issuance of Debt |
0
|
0
|
4
|
4
|
3
|
3
|
(1)
|
(1)
|
(3)
|
|
| Other |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
6
N/A
|
6
+3%
|
10
+59%
|
9
-4%
|
8
-13%
|
8
-5%
|
5
-37%
|
6
+21%
|
13
+130%
|
|
| Change in Cash | ||||||||||
| Net Change in Cash |
(5)
N/A
|
(5)
-6%
|
(2)
+69%
|
(2)
-19%
|
(5)
-173%
|
(4)
+23%
|
(4)
-13%
|
(2)
+54%
|
6
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(10)
N/A
|
(11)
-5%
|
(11)
-2%
|
(11)
+1%
|
(13)
-17%
|
(11)
+12%
|
(9)
+21%
|
(8)
+14%
|
(8)
+2%
|
|